LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Role of the CD40-CD40L expression level pathway in the diagnosis of unexplained recurrent pregnancy loss.

Ding, Hui / An, Guoqian

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

2023  Volume 43, Issue 2, Page(s) 2280840

Abstract: Background: Unexplained recurrent spontaneous pregnancy loss (URPL) lacks effective treatment and reliable early diagnosis and prediction. Immunologic dysfunction can be an underlying cause of recurrent pregnancy loss (RPL). Considering the regulatory ... ...

Abstract Background: Unexplained recurrent spontaneous pregnancy loss (URPL) lacks effective treatment and reliable early diagnosis and prediction. Immunologic dysfunction can be an underlying cause of recurrent pregnancy loss (RPL). Considering the regulatory role of CD40-CD40L in immune responses, we explored its clinical significance in URPL.
Methods: The 108 women with URPL who were treated in Hebei Yanda Hospital from January 2020 to December 2022 were selected as study subjects, and another 108 healthy women who were not pregnant and matched with the age and body mass index of the study group were selected as the control group. CD40 and CD4 + CD25 + Treg cells in peripheral blood mononuclear cells (PBMCs) and CD40L in peripheral blood platelets were measured by flow cytometry. The predictive value of CD40-CD40L in URPL for the risk of RPL was determined by receiver operating characteristic (ROC) curves. The correlations of CD40-CD40L with CD4 + CD25 + Treg cells and serum pro-inflammatory factors were assessed by Pearson's analysis.
Results: CD40 on the surface of PBMCs and CD40L on the surface of platelets were up-regulated in URPL patients. CD40 in combination with CD40L had high predictive value for the risk of RPL in URPL patients. Peripheral blood CD40-CD40L was positively linked to IL-17 and IL-23, and negatively to CD4 + CD25 + Treg cells and IL-10 in URPL patients.
Conclusions: The CD40-CD40L pathway expression in peripheral blood can help predict the risk of RPL in URPL patients.
MeSH term(s) Humans ; Pregnancy ; Female ; CD40 Ligand ; Leukocytes, Mononuclear ; Abortion, Habitual
Chemical Substances CD40 Ligand (147205-72-9)
Language English
Publishing date 2023-11-30
Publishing country England
Document type Journal Article
ZDB-ID 604639-3
ISSN 1364-6893 ; 0144-3615
ISSN (online) 1364-6893
ISSN 0144-3615
DOI 10.1080/01443615.2023.2280840
Shelf mark
Zs.B 2461: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top